Michael J. Schlosser, an officer at HCA Healthcare, Inc., has filed a notice to sell 1,200 shares of the company's common stock. This filing is significant as it highlights the ongoing compensation practices within the healthcare industry, particularly in the context of executive stock transactions.

Background

HCA Healthcare, Inc. is a leading provider in the healthcare services sector, specifically categorized under general medical and surgical hospitals. The company, which operates under the ticker symbol HCA on the NYSE, has a long history of providing comprehensive healthcare services across the United States. Recent filings include a Form 4 on November 2, 2026, and a Form 3 on September 11, 2026.

What the Filing Says

According to the filing dated November 4, 2026, Schlosser acquired the shares through the exercise of a stock appreciation right on October 29, 2026. The transaction reflects a compensatory payment, with an aggregate market value of approximately $593,583. The filing indicates that no other securities were sold in the past three months.

Impact

This transaction may impact perceptions of executive compensation within HCA Healthcare and the broader healthcare industry. As executive stock sales can influence investor sentiment, this filing provides insight into the company's compensation strategies and the financial interests of its leadership.

What's Next

The filing does not say what happens next.